table;code;text;level;year
atc;A;Alimentary tract and metabolism;1;2015
atc;A01A;Stomatological preparations;4;2015
atc;A01AA;Caries prophylactic agents;5;2015
atc;A01AB;Anti-infectives and antiseptics for local oral treatment;5;2015
atc;A01AC;Corticosteroids for local oral treatment;5;2015
atc;A01AD;Other agents for local oral treatment;5;2015
atc;A02;Drugs for acid related disorders;3;2015
atc;A02A;Antacid drugs (Stomach acid drugs);4;2015
atc;A02AA;Magnesium compounds;5;2015
atc;A02AB;Aluminium compounds;5;2015
atc;A02AC;Calcium compounds list;5;2015
atc;A02AD;Combinations and complexes of aluminium;5;2015
atc;A02AF;Antacids with antiflatulents;5;2015
atc;A02B;Drugs for peptic ulcer and gastro-oesophageal reflux disease;4;2015
atc;A02BA;H2-receptor antagonists;5;2015
atc;A02BB;Prostaglandins;5;2015
atc;A02BC;Proton pump inhibitors;5;2015
atc;A02BD;Combinations for eradication of Helicobacter pylori;5;2015
atc;A02BX;Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD/GERD);5;2015
atc;A02X;Other drugs for acid related disorders;4;2015
atc;A03;Drugs for functional gastrointestinal disorders;3;2015
atc;A03A;Drugs for functional bowel disorders;4;2015
atc;A03AA;Synthetic anticholinergics;5;2015
atc;A03AB;Synthetic anticholinergics;5;2015
atc;A03AC;Synthetic antispasmodics;5;2015
atc;A03AD;Papaverine and derivatives;5;2015
atc;A03AE;Serotonin receptor antagonists;5;2015
atc;A03AX;Other drugs for functional gastrointestinal disorders;5;2015
atc;A03B;Belladonna and derivatives;4;2015
atc;A03C;Antispasmodics in combination with psycholeptics;4;2015
atc;A03D;Antispasmodics in combination with analgesics;4;2015
atc;A03E;Antispasmodics and anticholinergics in combination with other drugs;4;2015
atc;A03F;Propulsives;4;2015
atc;A04A;Antiemetics and antinauseants;4;2015
atc;A04AA;Serotonin (5-HT3) antagonists;5;2015
atc;A04AA01;Ondansetron;7;2015
atc;A04AA02;Granisetron;7;2015
atc;A04AA03;Tropisetron;7;2015
atc;A04AA04;Dolasetron;7;2015
atc;A04AA05;Palonosetron;7;2015
atc;A04AA55;Palonosetron;7;2015
atc;A04AD;Other antiemetics;5;2015
atc;A04AD01;Scopolamine;7;2015
atc;A04AD02;Cerium oxalate;7;2015
atc;A04AD04;Chlorobutanol;7;2015
atc;A04AD05;Metopimazine;7;2015
atc;A04AD10;Dronabinol;7;2015
atc;A04AD11;Nabilone;7;2015
atc;A04AD12;Aprepitant;7;2015
atc;A04AD13;Casopitant;7;2015
atc;A04AD51;Scopolamine;7;2015
atc;A04AD54;Chlorobutanol;7;2015
atc;A05;Bile and liver therapy;3;2015
atc;A05A;Bile therapy;4;2015
atc;A05B;Liver therapy;4;2015
atc;A05C;Drugs for bile therapy and lipotropics in combination;4;2015
atc;A05AA;Bile acid preparations;5;2015
atc;A05AB;Preparations for biliary tract therapy;5;2015
atc;A05AX;Other drugs for bile therapy;5;2015
atc;A05BA;Liver therapy;5;2015
atc;A06A;Drugs for constipation;4;2015
atc;A06AA;Softeners;5;2015
atc;A06AB;Contact laxatives;5;2015
atc;A06AC;Bulk-forming laxatives;5;2015
atc;A06AD;Osmotically acting laxatives;5;2015
atc;A06AG;Enemas drugs;5;2015
atc;A06AH;Peripheral opioid receptor antagonists;5;2015
atc;A06AX;Other drugs for constipation;5;2015
atc;A07;Antidiarrheals;3;2015
atc;A07A;Intestinal anti-infectives;4;2015
atc;A07AA;Antibiotics;5;2015
atc;A07AB;Sulfonamides;5;2015
atc;A07AC;Imidazole derivatives;5;2015
atc;A07AX;Other intestinal anti-infectives;5;2015
atc;A07B;Intestinal adsorbents;4;2015
atc;A07BA;Charcoal preparations;5;2015
atc;A07BC;Other intestinal adsorbents;5;2015
atc;A07C;Electrolytes with carbohydrates;4;2015
atc;A07CA;Oral rehydration salt formulations;5;2015
atc;A07DA;Antipropulsives;5;2015
atc;A07E;Intestinal anti-inflammatory agents;4;2015
atc;A07EA;Corticosteroids acting locally;5;2015
atc;A07EB;Antiallergic agents;5;2015
atc;A07EC;Aminosalicylic acid and similar agents;5;2015
atc;A07FA;Antidiarrheal micro-organisms;5;2015
atc;A07XA;Other antidiarrheals;5;2015
atc;A08;Antiobesity preparations;3;2015
atc;A08A;Anti obesity drugs list;4;2015
atc;A08AA;Centrally acting anti obesity drugs;5;2015
atc;A08AB;Peripherally acting anti obesity drugs;5;2015
atc;A08AX;Other anti obesity drugs;5;2015
atc;A09A;Digestives;4;2015
atc;A09AA;Enzyme preparations;5;2015
atc;A09AB;Acid preparations;5;2015
atc;A09AC;Enzyme and acid preparations;5;2015
atc;A10;Drugs used in diabetes;3;2015
atc;A10A;Insulins and analogues;4;2015
atc;A10B;Blood glucose lowering drugs;4;2015
atc;A10X;Other drugs used in diabetes;4;2015
atc;A10AB;Insulins and analogues for injection;5;2015
atc;A10AC;Insulins and analogues for injection;5;2015
atc;A10AD;Insulins and analogues for injection;5;2015
atc;A10AE;Insulins and analogues for injection;5;2015
atc;A10AF;Insulins and analogues for inhalation;5;2015
atc;A10BA;Biguanides;5;2015
atc;A10BB;Sulfonylureas;5;2015
atc;A10BC;Sulfonamides (heterocyclic);5;2015
atc;A10BD;Combinations of oral blood glucose lowering drugs;5;2015
atc;A10BF;Alpha glucosidase inhibitors;5;2015
atc;A10BG;Thiazolidinediones;5;2015
atc;A10BH;Dipeptidyl peptidase 4 (DPP-4) inhibitors;5;2015
atc;A10BJ;Glucagon-like peptide-1 receptor (GLP-1) analogues;5;2015
atc;A10BK;Sodium-glucose co-transporter 2 (SGLT2) inhibitors;5;2015
atc;A10BX;Other blood glucose lowering drugs;5;2015
atc;A10XA;Aldose reductase inhibitors;5;2015
atc;A11;Vitamins;3;2015
atc;A11A;Multivitamins;4;2015
atc;A11B;Multivitamins;4;2015
atc;A11C;Vitamin A and D;4;2015
atc;A11D;Vitamin B1;4;2015
atc;A11E;Vitamin B-complex;4;2015
atc;A11G;Ascorbic acid (vitamin C);4;2015
atc;A11HA;Other plain vitamin preparations;5;2015
atc;A11J;Other vitamin products;4;2015
atc;A11AA;Multivitamins with minerals;5;2015
atc;A11AB;Multivitamins;5;2015
atc;A11CA;Vitamin A;5;2015
atc;A11CB;Vitamin A and D in combination;5;2015
atc;A11CC;Vitamin D and analogues;5;2015
atc;A11DA;Vitamin B1;5;2015
atc;A11DB;Vitamin B1 in combination with vitamin B6 and/or vitamin B12;5;2015
atc;A11EA;Vitamin B-complex;5;2015
atc;A11EB;Vitamin B-complex with vitamin C;5;2015
atc;A11EC;Vitamin B-complex with minerals;5;2015
atc;A11ED;Vitamin B-complex with anabolic steroids;5;2015
atc;A11EX;Vitamin B-complex;5;2015
atc;A11GA;Ascorbic acid (vitamin C);5;2015
atc;A11GB;Ascorbic acid (vitamin C);5;2015
atc;A11HA01;Nicotinamide;7;2015
atc;A11HA02;Pyridoxine (vitamin B6);7;2015
atc;A11HA03;Tocopherol (vitamin E);7;2015
atc;A11HA04;Riboflavin (vitamin B2);7;2015
atc;A11HA05;Biotin;7;2015
atc;A11HA06;Pyridoxal phosphate;7;2015
atc;A11HA07;Inositol;7;2015
atc;A11HA08;Tocofersolan;7;2015
atc;A11HA30;Dexpanthenol;7;2015
atc;A11HA31;Calcium pantothenate;7;2015
atc;A11HA32;Pantethine;7;2015
atc;A11JA;Combinations of vitamins;5;2015
atc;A11JB;Vitamins with minerals;5;2015
atc;A11JC;Vitamins;5;2015
atc;A12;Mineral supplements;3;2015
atc;A12A;Calcium;4;2015
atc;A12BA;Potassium;5;2015
atc;A12C;Other mineral supplements;4;2015
atc;A12AA;Calcium;5;2015
atc;A12AX;Calcium;5;2015
atc;A12CA;Sodium;5;2015
atc;A12CB;Zinc;5;2015
atc;A12CC;Magnesium;5;2015
atc;A12CD;Fluoride;5;2015
atc;A12CE;Selenium;5;2015
atc;A12CX;Other mineral products;5;2015
atc;A13;Tonics;3;2015
atc;A14;Anabolic agents for systemic use;3;2015
atc;A14A;Anabolic steroids;4;2015
atc;A14B;Other anabolic agents;4;2015
atc;A14AA;Androstan derivatives;5;2015
atc;A14AB;Estren derivatives;5;2015
atc;A15;Appetite stimulants;3;2015
atc;A16A;Other alimentary tract and metabolism products;4;2015
atc;A16AA;Amino acids and derivatives;5;2015
atc;A16AB;Enzymes;5;2015
atc;A16AX;Various alimentary tract and metabolism products;5;2015
atc;B;Blood and blood forming organs;1;2015
atc;B01A;Antithrombotic agents;4;2015
atc;B01AA;Vitamin K antagonists;5;2015
atc;B01AB;Heparin group;5;2015
atc;B01AC;Platelet aggregation inhibitors excluding heparin;5;2015
atc;B01AD;Enzymes;5;2015
atc;B01AE;Direct thrombin inhibitors;5;2015
atc;B01AF;Direct factor Xa inhibitors;5;2015
atc;B01AX;Other antithrombotic agents;5;2015
atc;B02;Antihemorrhagic drugs;3;2015
atc;B02A;Antifibrinolytics;4;2015
atc;B02AA;Amino acids;5;2015
atc;B02AB;Proteinase inhibitors;5;2015
atc;B02B;Vitamin K and other hemostatics;4;2015
atc;B02BA;Vitamin K;5;2015
atc;B02BB;Fibrinogen;5;2015
atc;B02BC;Local hemostatics;5;2015
atc;B02BD;Blood coagulation factors;5;2015
atc;B02BX;Other systemic hemostatics;5;2015
atc;B03;Antianemic drugs;3;2015
atc;B03A;Iron preparations;4;2015
atc;B03AA;Iron bivalent;5;2015
atc;B03AB;Iron trivalent;5;2015
atc;B03AD;Iron in combination with folic acid;5;2015
atc;B03AE;Iron in other combinations;5;2015
atc;B03B;Vitamin B12 and folic acid;4;2015
atc;B03BA;Vitamin B12 (cyanocobalamin and analogues);5;2015
atc;B03BB;Folic acid and derivatives;5;2015
atc;B03XA;Other antianemic preparations;5;2015
atc;B05;Blood substitutes and perfusion solutions;3;2015
atc;B05A;Blood and related products;4;2015
atc;B05AA;Blood substitutes and plasma protein fractions;5;2015
atc;B05AX;Other blood products;5;2015
atc;B05B;I.V. solutions;4;2015
atc;B05BA;Solutions for parenteral nutrition;5;2015
atc;B05BB;Solutions affecting the electrolyte balance;5;2015
atc;B05BC;Solutions producing osmotic diuresis;5;2015
atc;B05C;Irrigating solutions;4;2015
atc;B05CA;Antiinfectives;5;2015
atc;B05CB;Salt solutions;5;2015
atc;B05CX;Other irrigating solutions;5;2015
atc;B05X;I.V. solution additives;4;2015
atc;B05XA;Electrolyte solutions;5;2015
atc;B05XB;Amino acids;5;2015
atc;B05XX;Other i.v. solution additives;5;2015
atc;B06A;Other hematologic drugs;4;2015
atc;B06AA;Enzymes;5;2015
atc;B06AB;Other hematological products;5;2015
atc;B06AC;Drugs used in hereditary angioedema;5;2015
atc;C;Cardiovascular system;1;2015
atc;C01;Cardiac therapy;3;2015
atc;C01A;Cardiac glycosides list;4;2015
atc;C01AA;Digitalis glycosides;5;2015
atc;C01AB;Scilla glycosides;5;2015
atc;C01AC;Strophantus glycosides;5;2015
atc;C01AX;Other cardiac glycosides;5;2015
atc;C01B;Class 1 and 3 antiarrhythmic drugs;4;2015
atc;C01BA;Class 1a antiarrhythmic drugs;5;2015
atc;C01BB;Class 1b antiarrhythmic drugs;5;2015
atc;C01BC;Class 1c antiarrhythmic drugs;5;2015
atc;C01BD;Class 3 antiarrhythmic drugs;5;2015
atc;C01BG;Class 1 and 3 antiarrhythmic drugs;5;2015
atc;C01C;Cardiac stimulants excluding cardiac glycosides;4;2015
atc;C01CA;Adrenergic and dopaminergic agents;5;2015
atc;C01CE;Phosphodiesterase inhibitors drugs;5;2015
atc;C01CX;Other cardiac stimulants drugs;5;2015
atc;C01D;Vasodilators used in cardiac diseases;4;2015
atc;C01DA;Organic nitrates;5;2015
atc;C01DB;Quinolone vasodilators;5;2015
atc;C01DX;Other vasodilators used in cardiac diseases;5;2015
atc;C01E;Other cardiac preparations;4;2015
atc;C01EA;Prostaglandins;5;2015
atc;C01EB;Other cardiac preparations;5;2015
atc;C02;Antihypertensive drugs;3;2015
atc;C02A;Antiadrenergic agents;4;2015
atc;C02AA;Rauvolfia alkaloids;5;2015
atc;C02AB;Methyldopa;5;2015
atc;C02AC;Imidazoline receptor agonists;5;2015
atc;C02B;Antiadrenergic agents;4;2015
atc;C02BA;Sulfonium derivatives;5;2015
atc;C02BB;Secondary and tertiary amines;5;2015
atc;C02C;Antiadrenergic agents;4;2015
atc;C02CA;Alpha-adrenoreceptor antagonists;5;2015
atc;C02CC;Guanidine derivatives;5;2015
atc;C02D;Arteriolar smooth muscle;4;2015
atc;C02DA;Thiazide derivatives;5;2015
atc;C02DB;Hydrazinophthalazine derivatives;5;2015
atc;C02DC;Pyrimidine derivatives;5;2015
atc;C02DD;Nitroferricyanide derivatives;5;2015
atc;C02DG;Guanidine derivatives;5;2015
atc;C02K;Other antihypertensives;4;2015
atc;C02KA;Alkaloids;5;2015
atc;C02KB;Tyrosine hydroxylase inhibitors;5;2015
atc;C02KC;MAO inhibitors;5;2015
atc;C02KD;Serotonin antagonists;5;2015
atc;C02KX;Antihypertensives for pulmonary arterial hypertension;5;2015
atc;C02L;Antihypertensives and diuretics in combination;4;2015
atc;C02LA;Rauwolfia alkaloids and diuretics in combination;5;2015
atc;C02LB;Methyldopa and diuretics in combination;5;2015
atc;C02LC;Imidazoline receptor agonists in combination with diuretics;5;2015
atc;C02LE;Alpha-adrenoreceptor antagonists and diuretics;5;2015
atc;C02LF;Guanidine derivatives and diuretics;5;2015
atc;C02LG;Hydrazinophthalazine derivatives and diuretics;5;2015
atc;C02LK;Alkaloids in combination with diuretics;5;2015
atc;C02LL;MAO inhibitors and diuretics;5;2015
atc;C02LX;Other antihypertensives and diuretics;5;2015
atc;C03;Diuretic drugs;3;2015
atc;C03A;Low-ceiling diuretics;4;2015
atc;C03AA;Thiazides;5;2015
atc;C03AB;Thiazides and potassium in combination;5;2015
atc;C03AH;Thiazides;5;2015
atc;C03AX;Thiazides;5;2015
atc;C03B;Low-ceiling diuretics;4;2015
atc;C03BA;Sulfonamides;5;2015
atc;C03BB;Sulfonamides and potassium in combination;5;2015
atc;C03BC;Mercurial diuretics;5;2015
atc;C03BD;Xanthine derivatives;5;2015
atc;C03BX;Other low-ceiling diuretics;5;2015
atc;C03C;High-ceiling diuretics;4;2015
atc;C03CA;Sulfonamides;5;2015
atc;C03CB;Sulfonamides and potassium in combination;5;2015
atc;C03CC;Aryloxyacetic acid derivatives;5;2015
atc;C03CD;Pyrazolone derivatives;5;2015
atc;C03CX;Other high-ceiling diuretics;5;2015
atc;C03D;Potassium-sparing agents;4;2015
atc;C03DA;Aldosterone antagonists;5;2015
atc;C03DB;Other potassium-sparing agents;5;2015
atc;C03E;Diuretics and potassium-sparing agents in combination;4;2015
atc;C03EA;Low-ceiling diuretics and potassium-sparing agents;5;2015
atc;C03EB;High-ceiling diuretics and potassium-sparing agents;5;2015
atc;C03X;Other diuretics;4;2015
atc;C03XA;Vasopressin antagonists;5;2015
atc;C04;Peripheral vasodilators;3;2015
atc;C04A;Peripheral vasodilators;4;2015
atc;C04AA;2-amino-1-phenylethanol derivatives;5;2015
atc;C04AB;Imidazoline derivatives;5;2015
atc;C04AC;Nicotinic acid and derivatives;5;2015
atc;C04AD;Purine derivatives;5;2015
atc;C04AE;Ergot alkaloids;5;2015
atc;C04AF;Enzymes;5;2015
atc;C04AX;Other peripheral vasodilators;5;2015
atc;C05;Vasoprotective drugs;3;2015
atc;C05A;Agents for treatment of hemorrhoids and anal fissures for topical use;4;2015
atc;C05AA;Corticosteroids;5;2015
atc;C05AD;Local anesthetics;5;2015
atc;C05AE;Muscle relaxants;5;2015
atc;C05AX;Other agents for treatment of hemorrhoids and anal fissures for topical use;5;2015
atc;C05B;Antivaricose therapy;4;2015
atc;C05BA;Heparins or heparinoids for topical use;5;2015
atc;C05BB;Sclerosing agents for local injection;5;2015
atc;C05BX;Other sclerosing agents;5;2015
atc;C05C;Capillary stabilising agents;4;2015
atc;C05CA;Bioflavonoids;5;2015
atc;C05CX;Other capillary stabilising agents;5;2015
atc;C07;Beta blocking agents;3;2015
atc;C07A;Beta blocking agents;4;2015
atc;C07AA;Beta blocking agents;5;2015
atc;C07AB;Beta blocking agents;5;2015
atc;C07AG;Alpha and beta blocking agents;5;2015
atc;C07B;Beta blocking agents and thiazides;4;2015
atc;C07BA;Beta blocking agents and thiazides;5;2015
atc;C07BB;Beta blocking agents and thiazides;5;2015
atc;C07BG;Alpha and beta blocking agents and thiazides;5;2015
atc;C07C;Beta blocking agents and other diuretics;4;2015
atc;C07CA;Beta blocking agents and other diuretics;5;2015
atc;C07CB;Beta blocking agents and other diuretics;5;2015
atc;C07CG;Alpha and beta blocking agents and other diuretics;5;2015
atc;C07D;Beta blocking agents;4;2015
atc;C07DA;Beta blocking agents thiazides and other diuretics;5;2015
atc;C07DB;Beta blocking agents thiazides and other diuretics;5;2015
atc;C07F;Beta blocking agents and other antihypertensives;4;2015
atc;C07FA;Beta blocking agents and other antihypertensives;5;2015
atc;C07FB;Beta blocking agents and other antihypertensives;5;2015
atc;C07FX;Beta blocking agents;5;2015
atc;C08;Calcium channel blockers;3;2015
atc;C08C;Selective calcium channel blockers with mainly vascular effects;4;2015
atc;C08CA;Dihydropyridine derivatives;5;2015
atc;C08CX;Other selective calcium channel blockers with mainly vascular effects;5;2015
atc;C08D;Selective calcium channel blockers with direct cardiac effects;4;2015
atc;C08DA;Phenylalkylamine derivatives;5;2015
atc;C08DB;Benzothiazepine derivatives;5;2015
atc;C08E;Non-selective calcium channel blockers;4;2015
atc;C08EA;Phenylalkylamine derivatives;5;2015
atc;C08EX;Other non-selective calcium channel blockers;5;2015
atc;C08GA;Calcium channel blockers and diuretics;5;2015
atc;C09;Agents acting on the renin-angiotensin system;3;2015
atc;C09AA;ACE inhibitors;5;2015
atc;C09B;ACE inhibitors;4;2015
atc;C09BA;ACE inhibitors and diuretics;5;2015
atc;C09BB;ACE inhibitors and calcium channel blockers;5;2015
atc;C09BX;ACE inhibitors;5;2015
atc;C09CA;Angiotensin II antagonists;5;2015
atc;C09D;Angiotensin II antagonists;4;2015
atc;C09DA;Angiotensin II antagonists and diuretics;5;2015
atc;C09DB;Angiotensin II antagonists and calcium channel blockers;5;2015
atc;C09DX;Angiotensin II antagonists;5;2015
atc;C09X;Other agents acting on the renin-angiotensin system;4;2015
atc;C09XA;Renin-inhibitors;5;2015
atc;C10;Lipid modifying agents;3;2015
atc;C10A;Lipid modifying agents;4;2015
atc;C10AA;HMG CoA reductase inhibitors;5;2015
atc;C10AB;Fibrates;5;2015
atc;C10AC;Bile acid sequestrants;5;2015
atc;C10AD;Nicotinic acid and derivatives;5;2015
atc;C10AX;Other lipid modifying agents;5;2015
atc;C10B;Lipid modifying agents;4;2015
atc;C10BA;HMG CoA reductase inhibitors in combination with other lipid modifying agents;5;2015
atc;C10BX;HMG CoA reductase inhibitors;5;2015
atc;D;Dermatological drugs;1;2015
atc;D01;Antifungals for dermatological use;3;2015
atc;D01A;Antifungals for topical use;4;2015
atc;D01AA;Antibiotics;5;2015
atc;D01AC;Imidazole and triazole derivatives;5;2015
atc;D01AE;Other antifungals for topical use;5;2015
atc;D01BA;Antifungals for systemic use;5;2015
atc;D02;Emollients and protectants;3;2015
atc;D02A;Emollients and protectives;4;2015
atc;D02AE;Carbamide products;5;2015
atc;D02B;Protectives against UV-radiation;4;2015
atc;D02BA;Protectives against UV-radiation for topical use;5;2015
atc;D02BB;Protectives against UV-radiation for systemic use;5;2015
atc;D03;Treatment of wounds and ulcers;3;2015
atc;D03A;Cicatrizants;4;2015
atc;D03AA;Cod-liver oil ointments;5;2015
atc;D03AX;Other cicatrizants;5;2015
atc;D03B;Enzymes;4;2015
atc;D03BA;Proteolytic enzymes;5;2015
atc;D04;Antipyretics drugs;3;2015
atc;D04A;Antipruritics anesthetics etc.;4;2015
atc;D04AA;Topical antihistamines;5;2015
atc;D04AB;Topical anesthetics;5;2015
atc;D05;Antipsoriatic drugs;3;2015
atc;D05A;Antipsoriatics for topical use;4;2015
atc;D05AC;Antracen derivatives;5;2015
atc;D05AD;Psoralens for topical use;5;2015
atc;D05AX;Other antipsoriatics for topical use;5;2015
atc;D05B;Antipsoriatics for systemic use;4;2015
atc;D05BA;Psoralens for systemic use;5;2015
atc;D05BB;Retinoids for treatment of psoriasis;5;2015
atc;D05BX;Other antipsoriatics for systemic use;5;2015
atc;D06;Antibiotics and chemotherapeutics for dermatological use;3;2015
atc;D06A;Antibiotics for topical use;4;2015
atc;D06AA;Tetracycline and derivatives;5;2015
atc;D06AX;Other antibiotics for topical use;5;2015
atc;D06B;Chemotherapeutics for topical use;4;2015
atc;D06BA;Sulfonamides;5;2015
atc;D06BB;Antivirals;5;2015
atc;D06BX;Other chemotherapeutics;5;2015
atc;D07;Topical dermatological corticosteroids;3;2015
atc;D07A;Corticosteroids;4;2015
atc;D07AA;Corticosteroids;5;2015
atc;D07AB;Corticosteroids;5;2015
atc;D07AC;Corticosteroids;5;2015
atc;D07AD;Corticosteroids;5;2015
atc;D07B;Corticosteroids;4;2015
atc;D07BA;Corticosteroids combinations with antiseptics;5;2015
atc;D07BB;Corticosteroids combinations with antiseptics;5;2015
atc;D07BC;Corticosteroids combinations with antiseptics;5;2015
atc;D07C;Corticosteroids;4;2015
atc;D07CA;Corticosteroids combinations with antibiotics;5;2015
atc;D07CB;Corticosteroids combinations with antibiotics;5;2015
atc;D07CC;Corticosteroids combinations with antibiotics;5;2015
atc;D07CD;Corticosteroids combinations with antibiotics;5;2015
atc;D07X;Corticosteroids;4;2015
atc;D07XA;Corticosteroids other combinations;5;2015
atc;D07XB;Corticosteroids other combinations;5;2015
atc;D07XC;Corticosteroids other combinations;5;2015
atc;D08;Antiseptics and disinfectants drugs;3;2015
atc;D08A;Antiseptics and disinfectants;4;2015
atc;D08AA;Acridine derivatives;5;2015
atc;D08AC;Biguanides and amidines;5;2015
atc;D08AE;Phenol and derivatives;5;2015
atc;D08AF;Nitrofuran derivatives;5;2015
atc;D08AG;Iodine products;5;2015
atc;D08AH;Quinoline derivatives;5;2015
atc;D08AJ;Quaternary ammonium compounds;5;2015
atc;D08AK;Mercurial products;5;2015
atc;D08AL;Silver compounds;5;2015
atc;D08AX;Other antiseptics and disinfectants;5;2015
atc;D09;Medicated dressings;3;2015
atc;D09A;Medicated dressings;4;2015
atc;D09AA;Medicated dressings with antiinfectives;5;2015
atc;D09AB;Zinc bandages;5;2015
atc;D09AX;Soft paraffin dressings;5;2015
atc;D10;Acne drugs;3;2015
atc;D10A;Topical acne drugs;4;2015
atc;D10AA;Corticosteroids;5;2015
atc;D10AB;Preparations containing sulfur;5;2015
atc;D10AD;Retinoids for topical use in acne;5;2015
atc;D10AE;Peroxides;5;2015
atc;D10AF;Anti-infectives for treatment of acne;5;2015
atc;D10AX;Other anti-acne preparations for topical use;5;2015
atc;D10B;Anti-acne preparations for systemic use;4;2015
atc;D10BA;Retinoids for treatment of acne;5;2015
atc;D10BX;Other anti-acne preparations for systemic use;5;2015
atc;D11;Other dermatological drugs;3;2015
atc;D11A;Other dermatological preparations;4;2015
atc;D11AC;Medicated shampoos;5;2015
atc;D11AE;Androgens for topical use;5;2015
atc;D11AH;Agents for dermatitis;5;2015
atc;D11AX;Other dermatologicals;5;2015
atc;G;Genitourinary system and reproductive hormones;1;2015
atc;G01;Gynecological anti-infectives and antiseptics;3;2015
atc;G01A;Anti infectives and antiseptics;4;2015
atc;G01AA;Antibiotics;5;2015
atc;G01AB;Arsenic compounds;5;2015
atc;G01AC;Quinoline derivatives;5;2015
atc;G01AD;Organic acids;5;2015
atc;G01AE;Sulfonamides;5;2015
atc;G01AF;Imidazole derivatives;5;2015
atc;G01AG;Triazole derivatives;5;2015
atc;G01AX;Other anti-infectives and antiseptics;5;2015
atc;G02;Other gynecological drugs;3;2015
atc;G02A;Uterotonics;4;2015
atc;G02AB;Ergot alkaloids;5;2015
atc;G02AC;Ergot alkaloids and oxytocin including analogues;5;2015
atc;G02AD;Prostaglandins;5;2015
atc;G02B;Contraceptives for topical use;4;2015
atc;G02BA;Intrauterine contraceptives;5;2015
atc;G02BB;Intravaginal contraceptives;5;2015
atc;G02C;Other gynecologicals;4;2015
atc;G02CA;Sympathomimetics;5;2015
atc;G02CB;Prolactin inhibitors;5;2015
atc;G02CC;Anti-inflammatory products for vaginal administration;5;2015
atc;G02CX;Other gynecologicals;5;2015
atc;G03;Sex hormones and modulators of the genital system;3;2015
atc;G03A;Hormonal contraceptives for systemic use;4;2015
atc;G03AA;Progestogens and estrogens;5;2015
atc;G03AB;Progestogens and estrogens;5;2015
atc;G03AC;Progestogens;5;2015
atc;G03AD;Emergency contraceptives;5;2015
atc;G03B;Androgens;4;2015
atc;G03BA;3-oxoandrosten-(4) derivatives;5;2015
atc;G03BB;5-androstanon-(3) derivatives;5;2015
atc;G03C;Estrogens;4;2015
atc;G03CA;Natural and semisynthetic estrogens;5;2015
atc;G03CB;Synthetic estrogens;5;2015
atc;G03CC;Estrogens;5;2015
atc;G03CX;Other estrogens;5;2015
atc;G03D;Progestogens;4;2015
atc;G03DA;Pregnen-(4) derivatives;5;2015
atc;G03DB;Pregnadien derivatives;5;2015
atc;G03DC;Estren derivatives;5;2015
atc;G03E;Androgens and female sex hormones in combination;4;2015
atc;G03EA;Androgens and estrogens;5;2015
atc;G03EK;Androgens and female sex hormones in combination with other drugs;5;2015
atc;G03F;Progestogens and estrogens in combination;4;2015
atc;G03FA;Progestogens and estrogens;5;2015
atc;G03FB;Progestogens and estrogens;5;2015
atc;G03G;Gonadotropins and other ovulation stimulants;4;2015
atc;G03GA;Gonadotropins;5;2015
atc;G03GB;Ovulation stimulants;5;2015
atc;G03H;Antiandrogens;4;2015
atc;G03HA;Antiandrogens;5;2015
atc;G03HB;Antiandrogens and estrogens;5;2015
atc;G03X;Other sex hormones and modulators of the genital system;4;2015
atc;G04;Urological drugs;3;2015
atc;G04B;Urologicals;4;2015
atc;G04BA;Acidifiers;5;2015
atc;G04BC;Urinary concrement solvents;5;2015
atc;G04BD;Drugs for urinary frequency and incontinence;5;2015
atc;G04BE;Drugs used in erectile dysfunction;5;2015
atc;G04BX;Other urologicals;5;2015
atc;G04C;Drugs used in benign prostatic hypertrophy;4;2015
atc;G04CA;Alpha-adrenoreceptor antagonists;5;2015
atc;G04CB;Testosterone-5-alpha reductase inhibitors;5;2015
atc;G04CX;Other drugs used in benign prostatic hypertrophy;5;2015
atc;H;Systemic hormonal preparations;1;2015
atc;H01;Pituitary and hypothalamic hormones and analogues;3;2015
atc;H01A;Anterior pituitary lobe hormones and analogues;4;2015
atc;H01AA;Adrenocorticotropic hormone;5;2015
atc;H01AB;Thyrotropin;5;2015
atc;H01AC;Somatropin and somatropin agonists;5;2015
atc;H01AX;Other anterior pituitary lobe hormones and analogues;5;2015
atc;H01B;Posterior pituitary lobe hormones;4;2015
atc;H01BA;Vasopressin and analogues;5;2015
atc;H01BB;Oxytocin and analogues;5;2015
atc;H01C;Hypothalamic hormones;4;2015
atc;H01CA;Gonadotropin-releasing hormones;5;2015
atc;H01CB;Somatostatin and analogues;5;2015
atc;H01CC;Anti-gonadotropin-releasing hormones;5;2015
atc;H02;Corticosteroids systemic;3;2015
atc;H02A;Corticosteroids for systemic use;4;2015
atc;H02AA;Mineralocorticoids;5;2015
atc;H02AB;Glucocorticoids;5;2015
atc;H02BX;Corticosteroids for systemic use;5;2015
atc;H03;Thyroid therapy;3;2015
atc;H03A;Thyroid preparations;4;2015
atc;H03AA;Thyroid hormones;5;2015
atc;H03B;Antithyroid preparations;4;2015
atc;H03BA;Thiouracils;5;2015
atc;H03BB;Sulphur-containing imidazole derivatives;5;2015
atc;H03BC;Perchlorates;5;2015
atc;H03BX;Other antithyroid preparations;5;2015
atc;H04;Pancreatic hormones;3;2015
atc;H04AA;Glycogenolytic hormones;5;2015
atc;H05;Calcium homeostasis;3;2015
atc;H05AA;Parathyroid hormones and analogues;5;2015
atc;H05B;Anti-parathyroid agents;4;2015
atc;H05BA;Calcitonin preparations;5;2015
atc;H05BX;Other anti-parathyroid agents;5;2015
atc;J;Antiinfectives for systemic use;1;2015
atc;J01;Antibacterial drugs;3;2015
atc;J01AA;Tetracyclines;5;2015
atc;J01BA;Amphenicols;5;2015
atc;J01C;Beta lactam antibiotics;4;2015
atc;J01CA;Penicillins;5;2015
atc;J01CE;Beta-lactamase sensitive penicillins;5;2015
atc;J01CF;Beta-lactamase resistant penicillins;5;2015
atc;J01CG;Beta-lactamase inhibitors;5;2015
atc;J01CR;Combinations of penicillins;5;2015
atc;J01D;Other beta-lactam antibacterials;4;2015
atc;J01DB;First generation cephalosporins list;5;2015
atc;J01DC;Second generation cephalosporins list;5;2015
atc;J01DD;Third-generation cephalosporins;5;2015
atc;J01DE;Fourth-generation cephalosporins;5;2015
atc;J01DF;Monobactams;5;2015
atc;J01DH;Carbapenems;5;2015
atc;J01DI;Other cephalosporins and penems;5;2015
atc;J01E;Sulfonamides and trimethoprim;4;2015
atc;J01EA;Trimethoprim and derivatives;5;2015
atc;J01EB;Short-acting sulfonamides;5;2015
atc;J01EC;Intermediate-acting sulfonamides;5;2015
atc;J01ED;Long-acting sulfonamides;5;2015
atc;J01EE;Combinations of sulfonamides and trimethoprim;5;2015
atc;J01F;Macrolides;4;2015
atc;J01FA;Macrolide antibiotics;5;2015
atc;J01FF;Lincosamide antibiotics;5;2015
atc;J01FG;Streptogramin antibiotics;5;2015
atc;J01G;Aminoglycoside antibacterials;4;2015
atc;J01GA;Streptomycins;5;2015
atc;J01GB;Other aminoglycosides;5;2015
atc;J01M;Quinolone antibacterials;4;2015
atc;J01MA;Fluoroquinolones;5;2015
atc;J01MB;Other quinolones;5;2015
atc;J01RA;Combinations of antibacterials;5;2015
atc;J01X;Other antibacterial drugs;4;2015
atc;J01XA;Glycopeptide antibacterials;5;2015
atc;J01XB;Polymyxins;5;2015
atc;J01XC;Steroid antibacterials;5;2015
atc;J01XD;Imidazole derivatives;5;2015
atc;J01XE;Nitrofuran derivatives;5;2015
atc;J01XX;Other antibacterials;5;2015
atc;J02;Antimycotic drugs;3;2015
atc;J02A;Antimycotics for systemic use;4;2015
atc;J02AA;Antibiotics;5;2015
atc;J02AB;Imidazole derivatives;5;2015
atc;J02AC;Triazole derivatives;5;2015
atc;J02AX;Other antimycotics for systemic use;5;2015
atc;J04;Antimycobacterials;3;2015
atc;J04A;Drugs for treatment of tuberculosis;4;2015
atc;J04AA;Aminosalicylic acid and derivatives;5;2015
atc;J04AB;Antibiotics;5;2015
atc;J04AC;Hydrazides;5;2015
atc;J04AD;Thiocarbamide derivatives;5;2015
atc;J04AK;Other drugs for treatment of tuberculosis;5;2015
atc;J04AM;Combinations of drugs for treatment of tuberculosis;5;2015
atc;J04BA;Drugs for treatment of lepra;5;2015
atc;J05;Antiviral drugs;3;2015
atc;J05A;Direct acting antiviral drugs;4;2015
atc;J05AA;Thiosemicarbazones;5;2015
atc;J05AB;Nucleosides and nucleotides excluding reverse transcriptase inhibitors;5;2015
atc;J05AC;Cyclic amines;5;2015
atc;J05AD;Phosphonic acid derivatives;5;2015
atc;J05AE;Protease inhibitors;5;2015
atc;J05AF;Nucleoside and nucleotide reverse transcriptase inhibitors;5;2015
atc;J05AG;Non-nucleoside reverse transcriptase inhibitors;5;2015
atc;J05AH;Neuraminidase inhibitors;5;2015
atc;J05AR;Antivirals for treatment of HIV infections;5;2015
atc;J05AX;Other antivirals;5;2015
atc;J06;Immune sera and immunoglobulins;3;2015
atc;J06AA;Immune sera;5;2015
atc;J06B;Immunoglobulins;4;2015
atc;J06BA;Immunoglobulins;5;2015
atc;J06BB;Specific immunoglobulins;5;2015
atc;J06BC;Other immunoglobulins;5;2015
atc;J07;Vaccines;3;2015
atc;J07A;Bacterial vaccines;4;2015
atc;J07AC;Anthrax vaccines;5;2015
atc;J07AD;Brucellosis vaccines;5;2015
atc;J07AE;Cholera vaccines;5;2015
atc;J07AF;Diphtheria vaccines;5;2015
atc;J07AG;Haemophilus influenzae B vaccine;5;2015
atc;J07AH;Meningococcal vaccines;5;2015
atc;J07AJ;Pertussis vaccines;5;2015
atc;J07AK;Plague vaccines;5;2015
atc;J07AL;Pneumococcal vaccines;5;2015
atc;J07AM;Tetanus vaccines;5;2015
atc;J07AN;Tuberculosis vaccines;5;2015
atc;J07AP;Typhoid vaccines;5;2015
atc;J07AR;Typhus (exanthematicus) vaccines;5;2015
atc;J07B;Viral vaccines;4;2015
atc;J07BA;Encephalitis vaccines;5;2015
atc;J07BB;Influenza vaccines;5;2015
atc;J07BC;Hepatitis vaccines;5;2015
atc;J07BD;Measles vaccines;5;2015
atc;J07BE;Mumps vaccines;5;2015
atc;J07BF;Poliomyelitis vaccines;5;2015
atc;J07BG;Rabies vaccines;5;2015
atc;J07BH;Rotavirus diarrhea vaccines;5;2015
atc;J07BJ;Rubella vaccines;5;2015
atc;J07BK;Varicella zoster vaccines;5;2015
atc;J07BL;Yellow fever vaccines;5;2015
atc;J07BM;Papillomavirus vaccines;5;2015
atc;J07BX;Other viral vaccines;5;2015
atc;J07CA;Bacterial and viral vaccines;5;2015
atc;L;Antineoplastic and immunomodulating agents;1;2015
atc;L01;Antineoplastic drugs;3;2015
atc;L01A;Alkylating agents list;4;2015
atc;L01AA;Nitrogen mustard analogues;5;2015
atc;L01AB;Alkyl sulfonates;5;2015
atc;L01AC;Ethylene imines;5;2015
atc;L01AD;Nitrosoureas;5;2015
atc;L01AG;Epoxides;5;2015
atc;L01AX;Other alkylating agents;5;2015
atc;L01B;Antimetabolites;4;2015
atc;L01BA;Folic acid analogues;5;2015
atc;L01BB;Purine analogues;5;2015
atc;L01BC;Pyrimidine analogues;5;2015
atc;L01C;Plant alkaloids and other natural products;4;2015
atc;L01CA;Vinca alkaloids and analogues;5;2015
atc;L01CB;Podophyllotoxin derivatives;5;2015
atc;L01CC;Colchicine derivatives;5;2015
atc;L01CD;Taxanes;5;2015
atc;L01CX;Other plant alkaloids and natural products;5;2015
atc;L01D;Cytotoxic antibiotics and related substances;4;2015
atc;L01DA;Actinomycin;5;2015
atc;L01DB;Anthracyclines and related substances;5;2015
atc;L01DC;Other cytotoxic antibiotics;5;2015
atc;L01X;Other antineoplastic agents;4;2015
atc;L01XA;Platinum compounds;5;2015
atc;L01XB;Methylhydrazines;5;2015
atc;L01XC;Monoclonal antibodies;5;2015
atc;L01XD;Sensitizers used in photodynamic/radiation therapy;5;2015
atc;L01XE;Protein kinase inhibitors;5;2015
atc;L01XX;Other antineoplastic agents;5;2015
atc;L02;Endocrine therapy;3;2015
atc;L02A;Hormones and related agents;4;2015
atc;L02AA;Estrogens;5;2015
atc;L02AB;Progestogens;5;2015
atc;L02AE;Gonadotropin-releasing hormone analogues;5;2015
atc;L02B;Hormone antagonists and related agents;4;2015
atc;L02BA;Anti-estrogens;5;2015
atc;L02BB;Anti-androgens;5;2015
atc;L02BG;Aromatase inhibitors;5;2015
atc;L02BX;Other hormone antagonists and related agents;5;2015
atc;L03A;Immunostimulants drugs;4;2015
atc;L03AA;Colony stimulating factors;5;2015
atc;L03AB;Interferons;5;2015
atc;L03AC;Interleukins;5;2015
atc;L03AX;Other immunostimulants;5;2015
atc;L04A;Immunosuppressants drugs;4;2015
atc;L04AA;Selective immunosuppressants;5;2015
atc;L04AB;Tumor necrosis factor alpha (TNF-a) inhibitors;5;2015
atc;L04AC;Interleukin inhibitors;5;2015
atc;L04AD;Calcineurin inhibitors;5;2015
atc;L04AX;Other immunosuppressants;5;2015
atc;M;Musculoskeletal system;1;2015
atc;M01;Anti-inflammatory and antirheumatic drugs;3;2015
atc;M01A;Anti-inflammatory and antirheumatic products;4;2015
atc;M01AA;Butylpyrazolidines;5;2015
atc;M01AB;Acetic acid derivatives and related substances;5;2015
atc;M01AC;Oxicams;5;2015
atc;M01AE;Propionic acid derivatives;5;2015
atc;M01AG;Fenamate Drugs;5;2015
atc;M01AH;Coxibs;5;2015
atc;M01AX;Other anti-inflammatory and antirheumatic agents;5;2015
atc;M01B;Anti-inflammatory/antirheumatic agents in combination;4;2015
atc;M01BA;Anti-inflammatory/antirheumatic agents in combination with corticosteroids;5;2015
atc;M01C;Specific antirheumatic agents;4;2015
atc;M01CA;Quinolines;5;2015
atc;M01CB;Gold preparations;5;2015
atc;M01CC;Penicillamine and similar agents;5;2015
atc;M01CX;Other specific antirheumatic agents;5;2015
atc;M02;Topical products for joint and muscular pain;3;2015
atc;M02A;Topical products for joint and muscular pain;4;2015
atc;M02AA;Anti-inflammatory preparations;5;2015
atc;M02AB;Capsaicin and similar agents;5;2015
atc;M02AC;Preparations with salicylic acid derivatives;5;2015
atc;M02AX;Other topical products for joint and muscular pain;5;2015
atc;M03;Muscle relaxants;3;2015
atc;M03A;Muscle relaxants;4;2015
atc;M03AA;Curare alkaloids;5;2015
atc;M03AB;Choline derivatives;5;2015
atc;M03AC;Other quaternary ammonium compounds;5;2015
atc;M03AX;Other muscle relaxants;5;2015
atc;M03B;Muscle relaxants;4;2015
atc;M03BA;Carbamic acid esters;5;2015
atc;M03BB;Oxazol and triazine derivatives;5;2015
atc;M03BC;Ethers;5;2015
atc;M03BX;Other centrally acting agents;5;2015
atc;M03C;Muscle relaxants;4;2015
atc;M03CA;Dantrolene and derivatives;5;2015
atc;M04A;Antigout preparations;4;2015
atc;M04AA;Preparations inhibiting uric acid production;5;2015
atc;M04AB;Preparations increasing uric acid excretion;5;2015
atc;M04AC;Preparations with no effect on uric acid metabolism;5;2015
atc;M04AX;Other antigout preparations;5;2015
atc;M05B;Drugs affecting bone structure and mineralization;4;2015
atc;M05BA;Bisphosphonates;5;2015
atc;M05BB;Bisphosphonates;5;2015
atc;M05BC;Bone morphogenetic proteins;5;2015
atc;M05BX;Other drugs affecting bone structure and mineralization;5;2015
atc;M09A;Other drugs for disorders of the musculo-skeletal system;4;2015
atc;M09AA;Quinine and derivatives;5;2015
atc;M09AB;Enzymes;5;2015
atc;M09AX;Other drugs for disorders of the musculo-skeletal system;5;2015
atc;N;Nervous system;1;2015
atc;N01;Anesthetic drugs;3;2015
atc;N01A;General anesthetics list;4;2015
atc;N01AA;Ethers;5;2015
atc;N01AB;Halogenated hydrocarbons;5;2015
atc;N01AF;Barbiturates;5;2015
atc;N01AG;Barbiturates in combination with other drugs;5;2015
atc;N01AH;Opioid anesthetics;5;2015
atc;N01AX;Other general anesthetics;5;2015
atc;N01B;Local anesthesia drugs;4;2015
atc;N01BA;Esters of aminobenzoic acid;5;2015
atc;N01BB;Amides;5;2015
atc;N01BC;Esters of benzoic acid;5;2015
atc;N01BX;Other local anesthesia drugs;5;2015
atc;N02;Analgesic drugs;3;2015
atc;N02A;Opioid drugs list;4;2015
atc;N02AA;Natural opium alkaloids list;5;2015
atc;N02AB;Phenylpiperidine derivatives;5;2015
atc;N02AC;Diphenylpropylamine derivatives;5;2015
atc;N02AD;Benzomorphan derivatives;5;2015
atc;N02AE;Oripavine derivatives;5;2015
atc;N02AF;Morphinan derivatives;5;2015
atc;N02AG;Opioids in combination with antispasmodics;5;2015
atc;N02AJ;Opioids in combination with non-opioid analgesics;5;2015
atc;N02AX;Other opioids;5;2015
atc;N02B;Other analgesics and antipyretics;4;2015
atc;N02BA;Salicylic acid and derivatives;5;2015
atc;N02BB;Pyrazolones;5;2015
atc;N02BE;Anilides;5;2015
atc;N02BG;Other analgesics and antipyretics;5;2015
atc;N02C;Migraine medication;4;2015
atc;N02CA;Ergot alkaloids;5;2015
atc;N02CB;Corticosteroid derivatives;5;2015
atc;N02CC;Selective serotonin (5-HT1) agonists;5;2015
atc;N02CX;Other migraine drugs;5;2015
atc;N03A;Antiepileptic drugs;4;2015
atc;N03AA;Barbiturates and derivatives;5;2015
atc;N03AB;Hydantoin derivatives;5;2015
atc;N03AC;Oxazolidine derivatives;5;2015
atc;N03AD;Succinimide derivatives;5;2015
atc;N03AE;Benzodiazepine derivatives;5;2015
atc;N03AF;Carboxamide derivatives;5;2015
atc;N03AG;Fatty acid derivatives;5;2015
atc;N03AX;Other antiepileptics;5;2015
atc;N04;Antiparkinson drugs;3;2015
atc;N04A;Anticholinergic agents for Parkinson;4;2015
atc;N04AA;Tertiary amines;5;2015
atc;N04AB;Ethers chemically close to antihistamines;5;2015
atc;N04AC;Ethers of tropine or tropine derivatives;5;2015
atc;N04B;Dopaminergic agents;4;2015
atc;N04BA;Dopa and dopa derivatives;5;2015
atc;N04BB;Adamantane derivatives;5;2015
atc;N04BC;Dopamine agonists;5;2015
atc;N04BD;Monoamine oxidase B inhibitors;5;2015
atc;N04BX;Other dopaminergic agents;5;2015
atc;N05;Psycholeptics drugs;3;2015
atc;N05A;Antipsychotic drugs;4;2015
atc;N05AA;Phenothiazines with aliphatic side-chain;5;2015
atc;N05AB;Phenothiazines with piperazine structure;5;2015
atc;N05AC;Phenothiazines with piperidine structur;5;2015
atc;N05AD;Butyrophenone derivatives;5;2015
atc;N05AE;Indole derivatives drugs;5;2015
atc;N05AF;Thioxanthene derivatives;5;2015
atc;N05AG;Diphenylbutylpiperidine derivatives;5;2015
atc;N05AH;Diazepines thiazepines and oxepines;5;2015
atc;N05AL;Benzamide antipsychotics;5;2015
atc;N05AN;Lithium;5;2015
atc;N05AX;Other antipsychotics;5;2015
atc;N05B;Anxiolytic drugs;4;2015
atc;N05BA;Benzodiazepine derivatives anxiolytics;5;2015
atc;N05BB;Diphenylmethane derivatives;5;2015
atc;N05BC;Carbamates;5;2015
atc;N05BD;Dibenzo-bicyclo-octadiene derivatives;5;2015
atc;N05BE;Azaspirodecanedione derivatives;5;2015
atc;N05BX;Other anxiolytic drugs;5;2015
atc;N05C;Hypnotics and sedatives drugs;4;2015
atc;N05CA;Barbiturates;5;2015
atc;N05CB;Barbiturates;5;2015
atc;N05CC;Aldehydes and derivatives;5;2015
atc;N05CD;Benzodiazepine derivatives;5;2015
atc;N05CE;Piperidinedione drugs;5;2015
atc;N05CF;Benzodiazepine related drugs;5;2015
atc;N05CH;Melatonin receptor agonist drugs;5;2015
atc;N05CM;Other hypnotic and sedative drugs;5;2015
atc;N05CX;Hypnotics and sedatives in combination;5;2015
atc;N06;Psychoanaleptics;3;2015
atc;N06A;Antidepressant drugs;4;2015
atc;N06AA;Non-selective monoamine reuptake inhibitors;5;2015
atc;N06AB;Selective Serotonin Reuptake Inhibitors;5;2015
atc;N06AF;Monoamine oxidase inhibitors;5;2015
atc;N06AG;Monoamine oxidase A inhibitors;5;2015
atc;N06AX;Other antidepressant drugs;5;2015
atc;N06B;Psychostimulants;4;2015
atc;N06BA;Centrally acting sympathomimetics;5;2015
atc;N06BC;Xanthine derivatives;5;2015
atc;N06BX;Other psychostimulants and nootropics;5;2015
atc;N06C;Psycholeptics and psychoanaleptics in combination;4;2015
atc;N06CA;Antidepressants in combination with psycholeptics;5;2015
atc;N06D;Dementia drugs;4;2015
atc;N06DA;Anticholinesterase drugs;5;2015
atc;N06DX;Other anti-dementia drugs;5;2015
atc;N07;Other nervous system drugs;3;2015
atc;N07A;Parasympathomimetic drugs;4;2015
atc;N07AA;Anticholinesterase drugs;5;2015
atc;N07AB;Choline esters;5;2015
atc;N07AX;Other parasympathomimetics;5;2015
atc;N07B;Drugs used in addictive disorders;4;2015
atc;N07BA;Drugs used in nicotine dependence;5;2015
atc;N07BB;Drugs used in alcohol dependence;5;2015
atc;N07BC;Drugs used in opioid dependence;5;2015
atc;N07C;Antivertigo preparations;4;2015
atc;N07CA;Antivertigo drugs;5;2015
atc;N07XX;Other nervous system drugs;5;2015
atc;P;Antiparasitic products;1;2015
atc;P01;Antiprotozoal drugs;3;2015
atc;P01A;Agents against amoebiasis and other protozoal diseases;4;2015
atc;P01AA;Hydroxyquinoline derivatives;5;2015
atc;P01AB;Nitroimidazole derivatives;5;2015
atc;P01AC;Dichloroacetamide derivatives;5;2015
atc;P01AR;Arsenic compounds;5;2015
atc;P01AX;Other agents against amoebiasis and other protozoal diseases;5;2015
atc;P01B;Antimalarials;4;2015
atc;P01BA;Aminoquinolines;5;2015
atc;P01BB;Biguanides;5;2015
atc;P01BC;Methanolquinolines;5;2015
atc;P01BD;Diaminopyrimidines;5;2015
atc;P01BE;Artemisinin and derivatives;5;2015
atc;P01BF;Artemisinin and derivatives;5;2015
atc;P01BX;Other antimalarials;5;2015
atc;P01C;Agents against leishmaniasis and trypanosomiasis;4;2015
atc;P01CA;Nitroimidazole derivatives;5;2015
atc;P01CB;Antimony compounds;5;2015
atc;P01CC;Nitrofuran derivatives;5;2015
atc;P01CD;Arsenic compounds;5;2015
atc;P01CX;Other agents against leishmaniasis and trypanosomiasis;5;2015
atc;P02;Anthelmintic drugs;3;2015
atc;P02B;Antitrematodals;4;2015
atc;P02BA;Quinoline derivatives and related substances;5;2015
atc;P02BB;Organophosphorous compounds;5;2015
atc;P02BX;Other antitrematodal agents;5;2015
atc;P02C;Antinematodal agents;4;2015
atc;P02CA;Benzimidazole derivatives;5;2015
atc;P02CB;Piperazine and derivatives;5;2015
atc;P02CC;Tetrahydropyrimidine derivatives;5;2015
atc;P02CE;Imidazothiazole derivatives;5;2015
atc;P02CF;Avermectines;5;2015
atc;P02CX;Other antinematodals;5;2015
atc;P02D;Anticestodals;4;2015
atc;P02DA;Salicylic acid derivatives;5;2015
atc;P02DX;Other anticestodals;5;2015
atc;P03;Ectoparasiticides insecticides and repellents;3;2015
atc;P03A;Ectoparasiticides;4;2015
atc;P03AA;Sulfur containing products;5;2015
atc;P03AB;Chlorine containing products;5;2015
atc;P03AC;Pyrethrines;5;2015
atc;P03AX;Other ectoparasiticides;5;2015
atc;P03B;Insecticides and repellents;4;2015
atc;P03BA;Pyrethrines;5;2015
atc;P03BX;Other insecticides and repellents;5;2015
atc;R;Respiratory system;1;2015
atc;R01;Nasal preparations;3;2015
atc;R01A;Decongestants and other nasal preparations for topical use;4;2015
atc;R01AA;Sympathomimetics;5;2015
atc;R01AB;Sympathomimetics;5;2015
atc;R01AC;Antiallergic agents;5;2015
atc;R01AD;Corticosteroids;5;2015
atc;R01AX;Other nasal preparations;5;2015
atc;R01BA;Nasal decongestants for systemic use;5;2015
atc;R02A;Throat drugs;4;2015
atc;R02AA;Throat antiseptics;5;2015
atc;R02AB;Throat antibiotics;5;2015
atc;R02AD;Anesthetics;5;2015
atc;R02AX;Other throat preparations;5;2015
atc;R03;Drugs for obstructive airway diseases;3;2015
atc;R03A;Adrenergics;4;2015
atc;R03AA;Alpha and beta adrenoreceptor agonists;5;2015
atc;R03AB;Non-selective beta-adrenoreceptor agonists;5;2015
atc;R03AC;Selective beta-2-adrenoreceptor agonists;5;2015
atc;R03AH;Combinations of adrenergics;5;2015
atc;R03AK;Adrenergics in combination with corticosteroids or other drugs;5;2015
atc;R03AL;Adrenergics in combination with anticholinergics;5;2015
atc;R03B;Other drugs for obstructive airway diseases;4;2015
atc;R03BA;Glucocorticoids;5;2015
atc;R03BB;Anticholinergics;5;2015
atc;R03BC;Antiallergic agents;5;2015
atc;R03BX;Other drugs for obstructive airway diseases;5;2015
atc;R03C;Adrenergics for systemic use;4;2015
atc;R03CA;Alpha- and beta-adrenoreceptor agonists;5;2015
atc;R03CB;Non-selective beta-adrenoreceptor agonists;5;2015
atc;R03CC;Selective beta-2-adrenoreceptor agonists;5;2015
atc;R03CK;Adrenergics and other drugs for obstructive airway diseases;5;2015
atc;R03D;Other systemic drugs for obstructive airway diseases;4;2015
atc;R03DA;Xanthines;5;2015
atc;R03DB;Xanthines and adrenergics;5;2015
atc;R03DC;Leukotriene receptor antagonists;5;2015
atc;R03DX;Other systemic drugs for obstructive airway diseases;5;2015
atc;R05;Cough and cold drugs;3;2015
atc;R05C;Expectorants;4;2015
atc;R05CA;Expectorants;5;2015
atc;R05CB;Mucolytics;5;2015
atc;R05D;Cough suppressants;4;2015
atc;R05DA;Opium alkaloids and derivatives;5;2015
atc;R05DB;Other cough suppressants;5;2015
atc;R05F;Cough suppressants and expectorants;4;2015
atc;R05FA;Opium derivatives and expectorants;5;2015
atc;R05FB;Other cough suppressants and expectorants;5;2015
atc;R06A;Antihistamines for systemic use;4;2015
atc;R06AA;Aminoalkyl ethers;5;2015
atc;R06AB;Substituted alkylamines;5;2015
atc;R06AC;Substituted ethylene diamines;5;2015
atc;R06AD;Phenothiazine derivatives;5;2015
atc;R06AE;Piperazine derivatives;5;2015
atc;R06AX;Other antihistamines for systemic use;5;2015
atc;R07A;Other respiratory system products;4;2015
atc;R07AA;Lung surfactants;5;2015
atc;R07AB;Respiratory stimulants;5;2015
atc;R07AX;Other respiratory system products;5;2015
atc;S;Sensory organs;1;2015
atc;S01;Ophthalmological drugs;3;2015
atc;S01A;Eye Anti-infectives;4;2015
atc;S01AA;Eye Antibiotics;5;2015
atc;S01AB;Eye Sulfonamides;5;2015
atc;S01AD;Eye Antivirals;5;2015
atc;S01AE;Eye Fluoroquinolones;5;2015
atc;S01AX;Other Eye anti-infectives;5;2015
atc;S01B;Anti-inflammatory agents;4;2015
atc;S01BA;Corticosteroids;5;2015
atc;S01BB;Corticosteroids and mydriatics in combination;5;2015
atc;S01BC;Anti-inflammatory agents;5;2015
atc;S01C;Anti-inflammatory agents and anti-infectives in combination;4;2015
atc;S01CA;Corticosteroids and anti-infectives in combination;5;2015
atc;S01CB;Corticosteroids / anti-infectives / mydriatics in combination;5;2015
atc;S01CC;Anti-inflammatory agents;5;2015
atc;S01E;Antiglaucoma preparations and miotics;4;2015
atc;S01EA;Sympathomimetics in glaucoma therapy;5;2015
atc;S01EB;Parasympathomimetics;5;2015
atc;S01EC;Carbonic anhydrase inhibitors;5;2015
atc;S01ED;Beta blocking agents;5;2015
atc;S01EE;Prostaglandin analogues;5;2015
atc;S01EX;Other antiglaucoma preparations;5;2015
atc;S01F;Mydriatics and cycloplegics;4;2015
atc;S01FA;Anticholinergics;5;2015
atc;S01FB;Sympathomimetics excluding antiglaucoma preparations;5;2015
atc;S01G;Decongestants and antiallergics;4;2015
atc;S01GA;Sympathomimetics used as decongestants;5;2015
atc;S01GX;Other antiallergics;5;2015
atc;S01HA;Local anesthetics;5;2015
atc;S01J;Diagnostic agents;4;2015
atc;S01JA;Colouring agents;5;2015
atc;S01K;Surgical aids;4;2015
atc;S01KA;Viscoelastic substances;5;2015
atc;S01KX;Other surgical aids;5;2015
atc;S01L;Ocular vascular disorder agents;4;2015
atc;S01LA;Antineovascularisation agents;5;2015
atc;S01XA;Other ophthalmologicals;5;2015
atc;S02;Otologicals;3;2015
atc;S02AA;Anti-infectives;5;2015
atc;S02BA;Corticosteroids;5;2015
atc;S02CA;Corticosteroids and anti-infectives in combination;5;2015
atc;S02D;Other otologicals;4;2015
atc;S02DA;Analgesics and anesthetics;5;2015
atc;S03;Ophthalmological and otological preparations;3;2015
atc;S03AA;Anti-infectives;5;2015
atc;S03BA;Corticosteroids;5;2015
atc;S03CA;Corticosteroids and anti-infectives in combination;5;2015
atc;V;Various ATC structures;1;2015
atc;V01AA;Allergen extracts;5;2015
atc;V03A;All other therapeutic products;4;2015
atc;V03AB;Antidotes;5;2015
atc;V03AC;Iron chelating agents;5;2015
atc;V03AE;Drugs for treatment of hyperkalemia and hyperphosphatemia;5;2015
atc;V03AF;Detoxifying agents for antineoplastic treatment;5;2015
atc;V03AG;Drugs for treatment of hypercalcemia;5;2015
atc;V03AH;Drugs for treatment of hypoglycaemia;5;2015
atc;V03AK;Tissue adhesives;5;2015
atc;V03AM;Drugs for embolisation;5;2015
atc;V03AN;Medical gases;5;2015
atc;V03AX;Other therapeutic products;5;2015
atc;V03AZ;Nerve depressants;5;2015
atc;V04;Diagnostic agents;3;2015
atc;V04B;Urine tests;4;2015
atc;V04C;Other diagnostic agents;4;2015
atc;V04CA;Tests for diabetes;5;2015
atc;V04CB;Tests for fat absorption;5;2015
atc;V04CC;Tests for bile duct patency;5;2015
atc;V04CD;Tests for pituitary function;5;2015
atc;V04CE;Tests for liver functional capacity;5;2015
atc;V04CF;Tuberculosis diagnostics;5;2015
atc;V04CG;Tests for gastric secretion;5;2015
atc;V04CH;Tests for renal function and ureteral injuries;5;2015
atc;V04CJ;Tests for thyreoidea function;5;2015
atc;V04CK;Tests for pancreatic function;5;2015
atc;V04CL;Tests for allergic diseases;5;2015
atc;V04CM;Tests for fertility disturbances;5;2015
atc;V06;General nutrients;3;2015
atc;V06A;Diet formulations for treatment of obesity;4;2015
atc;V06B;Protein supplements;4;2015
atc;V06C;Infant formulas;4;2015
atc;V06D;Other nutrients;4;2015
atc;V06DC;Carbohydrates;5;2015
atc;V07;All other non-therapeutic products;3;2015
atc;V08;Contrast media;3;2015
atc;V08A;X-ray contrast media;4;2015
atc;V08AA;Water-soluble high osmolar X-ray contrast media;5;2015
atc;V08AB;Water-soluble low osmolar X-ray contrast media;5;2015
atc;V08AC;Water-soluble;5;2015
atc;V08AD;Non-watersoluble X-ray contrast media;5;2015
atc;V08B;X-ray contrast media;4;2015
atc;V08BA;Barium sulfate containing X-ray contrast media;5;2015
atc;V08C;Magnetic resonance imaging contrast media;4;2015
atc;V08CA;Paramagnetic contrast media;5;2015
atc;V08CB;Superparamagnetic contrast media;5;2015
atc;V08CX;Other magnetic resonance imaging contrast media;5;2015
atc;V08DA;Ultrasound contrast media;5;2015
atc;V09;Diagnostic radiopharmaceuticals;3;2015
atc;V09A;Central nervous system;4;2015
atc;V09AA;Technetium (99mTc) compounds;5;2015
atc;V09AB;Iodine (123I) compounds;5;2015
atc;V09AX;Other central nervous system diagnostic radiopharmaceuticals;5;2015
atc;V09B;Skeleton;4;2015
atc;V09BA;Technetium (99mTc) compounds;5;2015
atc;V09C;Renal system;4;2015
atc;V09CA;Technetium (99mTc) compounds;5;2015
atc;V09CX;Other renal system diagnostic radiopharmaceuticals;5;2015
atc;V09D;Hepatic and reticulo endothelial system;4;2015
atc;V09DA;Technetium (99mTc) compounds;5;2015
atc;V09DB;Technetium (99mTc);5;2015
atc;V09DX;Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals;5;2015
atc;V09E;Respiratory system;4;2015
atc;V09EA;Technetium (99mTc) inhalants;5;2015
atc;V09EB;Technetium (99mTc) particles for injection;5;2015
atc;V09EX;Other respiratory system diagnostic radiopharmaceuticals;5;2015
atc;V09F;Thyroid;4;2015
atc;V09FX;Various thyroid diagnostic radiopharmaceuticals;5;2015
atc;V09G;Cardiovascular system;4;2015
atc;V09GA;Technetium (99mTc) compounds;5;2015
atc;V09GB;Iodine (125I) compounds;5;2015
atc;V09GX;Other cardiovascular system diagnostic radiopharmaceuticals;5;2015
atc;V09H;Inflammation and infection detection;4;2015
atc;V09HA;Technetium (99mTc) compounds;5;2015
atc;V09HB;Indium (111In) compounds;5;2015
atc;V09HX;Other diagnostic radiopharmaceuticals for inflammation and infection detection;5;2015
atc;V09I;Tumour detection;4;2015
atc;V09IA;Technetium (99mTc) compounds;5;2015
atc;V09IB;Indium (111In) compounds;5;2015
atc;V09IX;Other diagnostic radiopharmaceuticals for tumour detection;5;2015
atc;V09X;Other diagnostic radiopharmaceuticals;4;2015
atc;V09XA;Iodine (131I) compounds;5;2015
atc;V09XX;Various diagnostic radiopharmaceuticals;5;2015
atc;V10;Therapeutic radiopharmaceuticals;3;2015
atc;V10A;Anti-inflammatory agents;4;2015
atc;V10AA;Yttrium (90Y) compounds;5;2015
atc;V10AX;Other anti-inflammatory therapeutic radiopharmaceuticals;5;2015
atc;V10B;Pain palliation (bone seeking agents);4;2015
atc;V10BX;Various pain palliation radiopharmaceuticals;5;2015
atc;V10X;Other therapeutic radiopharmaceuticals;4;2015
atc;V10XA;Iodine (131I) compounds;5;2015
atc;V10XX;Various therapeutic radiopharmaceuticals;5;2015
atc;V20;Surgical dressings;3;2015
